OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
ENDO
Endocan Corporation
Class A Common Stock
Filings and Disclosure
OTC Disclosure & News Service
Active
Inactive
All
Publish Date Publish Date | Title Title | Period End Date Period End Date | Status Status |
|---|---|---|---|
| 08/25/2021 | Quarterly Report - March 31, 2021 Quarterls Disclosure Statement Amended Final | 03/31/2021 | A |
| 08/25/2021 | Annual Report - 2020 Annual Report Final Amended Disclose Agreement | 12/31/2020 | A |
| 08/16/2021 | Quarterly Report - Disclosure Statement Q2 2021 | 06/30/2021 | A |
| 08/16/2021 | Quarterly Report - Notes to Q2 2021 | 06/30/2021 | A |
| 08/16/2021 | Quarterly Report - ENDO 10Q Q2 | 06/30/2021 | A |
| 08/16/2021 | Quarterly Report - ENDO QB Report | 06/30/2021 | A |
| 08/12/2021 | Attorney Letter with Respect to Current Information - Legal Opinion for Annual Report date 12/31/2020 and quarterly date 3/31/21 | 03/31/2021 | A |
| 08/10/2021 | Quarterly Report | 03/31/2021 | A |
| 08/10/2021 | Quarterly Report | 12/31/2020 | A |
| 08/10/2021 | Quarterly Report - Disclosure Resolution March 31, 2021 | 03/31/2021 | A |
More
Displaying 10 of 16 Disclosure & News
SEC Filings
Form Type Form Type | Received Received | Period End Date Period End Date | Report Report |
|---|---|---|---|
| 15-15D | 12/12/2019 | ||
| 3 | 11/17/2016 | 05/14/2015 | |
| 8-K | 09/20/2016 | 09/14/2016 | |
| 4 | 03/01/2016 | 01/18/2016 | |
| 4 | 02/22/2016 | 01/19/2016 | |
| 4 | 09/10/2015 | 06/30/2015 | |
| 3/A | 06/18/2015 | 06/27/2013 | |
| 8-K | 05/20/2015 | 05/14/2015 | |
| 3 | 05/19/2015 | 01/11/2013 | |
| 3 | 02/11/2015 | 06/27/2013 |
More
Displaying 10 of 324 Filings
Insider Disclosure
OTC Disclosure & News
No insider disclosure available for endo.
SEC Transactions Last 6 Months
Buy / Sell
Buys
0Sells
0Total
0Shares
Bought
0Sold
0Gross
0Net
0SEC Transactions Last 2 Years
No SEC transactions available for endo.
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
49.74
Change
2.04 (4.28%)
Bid
47.95
Ask
49.74
Volume
11698
Time
00:00
